Psych Vivas · Emergency psychiatry
Lithium toxicity — structured clinical viva
Fellowship viva on lithium toxicity patterns, interactions, EXTRIP criteria, decontamination myths, rebound, and restart.
On this page & tools
Target exams
Interpretation
Reveal interpretation
Reject the junior plan. Activated charcoal does not bind lithium. Forced loop-diuretic diuresis is not the primary detox strategy. Waiting for Li greater than 5 before nephrology is unsafe: EXTRIP recommends ECTR for decreased consciousness at any lithium level and for impaired kidney function with Li greater than 4.0; it suggests ECTR for significant confusion and when expected time to Li less than 1.0 exceeds 36 hours. This patient is drowsy with AKI and Li 3.1 — call nephrology/toxicology now.[1][2]
Pattern. Chronic / acute-on-chronic toxicity precipitated by NSAID (naproxen) and thiazide-like diuretic (indapamide) plus age-related clearance risk. Neuro-dominant phenotype; severity can outrun the numerical band expected from acute naive overdose.[5][3]
Immediate care. Stop lithium, stop naproxen and indapamide, ABC support, ECG monitoring, serial levels, U&E, isotonic saline for volume repletion, early ECTR decision with HD preferred if indicated, plan for rebound checks.[1][2]
SILENT. Warn that severe neurotoxicity can leave persistent cerebellar/extrapyramidal deficits after levels normalise — motivates aggressive timely care.[4]
Aftercare. Fix interaction pathway; monitoring education; nuanced restart weighing anti-suicide benefit after recovery.[6][3]
Escalating viva probes
- Why does thiazide raise lithium? Volume depletion → increased proximal Na reabsorption → lithium follows.
- Name EXTRIP recommended criteria verbatim.
- What is rebound and when do you recheck?
- Define SILENT.
- Would you ever restart lithium? When, with what safeguards?
Key points
[1] [2] [5]References
- [1]Decker BS, Goldfarb DS, Dargan PI, et al. Extracorporeal Treatment for Lithium Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup Clin J Am Soc Nephrol, 2015.PMID 25583292
- [2]Waring WS Management of lithium toxicity Toxicol Rev, 2006.PMID 17288494
- [3]Finley PR Drug Interactions with Lithium: An Update Clin Pharmacokinet, 2016.PMID 26936045
- [4]Adityanjee, Munshi KR, Thampy A The syndrome of irreversible lithium-effectuated neurotoxicity Clin Neuropharmacol, 2005.PMID 15714160
- [5]Waring WS, Laing WJ, Good AM, et al. Pattern of lithium exposure predicts poisoning severity: evaluation of referrals to a regional poisons unit QJM, 2007.PMID 17412747
- [6]Cipriani A, Hawton K, Stockton S, et al. Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis BMJ, 2013.PMID 23814104